Professional Experience

• 인하대학교 대학원 바이오메디컬 사이언스·엔지니어링 협동과정 전공주임 (2021 - 2022)

• 인하대학교 대학원 바이오메디컬 사이언스·엔지니어링 협동과정 교수 (2020 - Present)

•  BK21 정밀의학 스마트공학 융합 교육연구단 부단장 (2020- Present)

•  Editorial Board, International Journal of Molecular Science (Jul 2020 - Present)

•  IRB Committee, Clinical Trial Center, Inha University Hospital (May 2020 - Present)

•  인하대학교 대학원 의과학과 전공주임 (2019 - 2022)

•  한국연구재단 기초연구본부 성과분석 전문위원 (May 2019 - Present)

•  한국연구재단 의약학단 전문위원(RB, Nov 2018 - 2021)

•  대한암학회 이사 (Jan 2017– Present)

•  인하대학교 연구관리위원회 위원(Sep 2016– Present)

•  미래창조과학부 중견연구자지원사업 도약 연구책임자 (Nov 2015-Present)

•  Vice-Director, Inha Research Institute for Medical Sciences, Inha University(Feb 2016 – Jun 2018)

•  대한약학회 연구기획 간사 (Jan 2015 – Jan 2017)

•  한국보건산업진흥원 전문위원(PM) (Jul 2013 - Jul 2015)

•  한국발명진흥회 특허기술평가 전문위원(Jan 2013 - Jan 2016)

•  한국약제학회 학술위원(Jan 2013 – Dec 2013)

•  Editorial Board, Molecular and Clinical Oncology (Apr 2012 – present)

•  Editorial Board, European Journal of Molecular Cancer (Sep2018- present)

•  Inha Fellow Professor (Distinguished Professor), Inha University (2012– 2018)

•  Associate Professor, School of Medicine, Inha University, Korea (Sep 2011 – Aug 2016)

•  Vice Director, Translational Research Center, Inha University Hospital (May 2012- Feb 2013)

•  Contributing Associate Editors-in-Chief, World Journal of Gastroenterology (2011-2015)

•  Associate Editor, Archives of Pharmacal Research (Jan 2011- Jan 2013)

•  Editorial Board, Journal of Pharmaceutical Investigation (Jan 2012-Dec 2012)

•  Chair, IRB for Bioequivalence Test, Inha University Hospital (Sep 2009-Aug 2012)

•  IRB Special Committee, Clinical Trial Center, Inha University Hospital (Sep 2008 - Aug 2012)

•  Assistant Professor, School of Medicine, Inha University, Korea (Sep 2007 – Aug 2011)

•  Research Assistant Professor, Center for Advanced Medical Education (BK21), School of Medicine,      

• Inha University, Korea (Aug 2006 - Aug 2007)

•  Research Consultant, Youl Chon Chemical Co., Ltd. (Mar 2006 – Feb 2009)

•  Senior Scientist, Research Institute of Pharmaceutical Science, Seoul National University, Korea

• Advisor: Kyu-Won Kim (May 2003 – Aug 2006)

•  Postdoctoral Associate, Yale University School of Medicine, CT, USA

• Advisor: Ying Xia (Dec 2001- May 2003)

•  Research Scientist, Dept. of Pharmaceutics, Research Institute of Pharmaceutical Science, Seoul

• National University, Korea (Mar 2001 – Mar 2003)

​

Honor/Awards
 

• 국무총리상 (제 7회 암 예방의 날, 2014.03.21)

• 우수 연구상 (인하대학교 의료원, 2020/ 2019 / 2018 / 2011)

•  Distinguished Poster Presentation Award, Annual Meeting of the Pharmaceutical Society of Korea (2014) “Synergic Effect of Gemcitabine by a Novel PI3K Inhibitor in Pancreatic Cancer”

•  Distinguished Poster Presentation Award, Annual Meeting of the Pharmaceutical Society of Korea (2011) “Human bone marrow-derived clonal mesenchymal stem cells alleviated acute pancreatitis by inhibiting inflammatory response”

•  Distinguished Poster Presentation Award, Annual Meeting of the Pharmaceutical Society of Korea (2010) “HS-104, a novel phosphatidylinositol 3-kinase inhibitor, elicits anticancer activities in human liver cancer cells”

•  Best Presentation Awards, the 1st Asia Pacific ISSX Meeting (2006)

• Post-Doctoral Fellowship, Korea Science and Engineering Foundation (2001~2003)

• Young Scientist Fellowship, Korea Research Foundation (2000-2001)